Just Healthcare

Just Healthcare

Share this post

Just Healthcare
Just Healthcare
Analysis highlights limited benefits of antivirals for nonsevere influenza.
Copy link
Facebook
Email
Notes
More

Analysis highlights limited benefits of antivirals for nonsevere influenza.

Insights from a Meta-Analysis on the Efficacy of Antivirals for Nonsevere Influenza Cases

Naveen Sankar S's avatar
Naveen Sankar S
Jan 28, 2025
∙ Paid
2

Share this post

Just Healthcare
Just Healthcare
Analysis highlights limited benefits of antivirals for nonsevere influenza.
Copy link
Facebook
Email
Notes
More
1
Share

Topline

A meta-analysis suggests that most antivirals, including oseltamivir and zanamivir, offer limited benefits for nonsevere influenza cases, while baloxavir shows potential for reducing symptom duration and hospitalization in high-risk patients.

Study Details

Influenza continues to pose significant health risks globally, particularly among high-risk p…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Just Healthcare
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More